Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

NCT00462488

Conditions
Bladder Cancer, Bladder Neoplasms, Bladder Tumors, +12 more
Locations
  • Southeastern Research Group, Inc. Tallahassee, Florida, United States
  • Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Lawrenceville Urology Lawrenceville, New Jersey, United States
  • Duke University Medical Center Durham, North Carolina, United States
View all 21 locations
View Trial Details
Completed

NANOTECH RCC Biomarkers

NCT02923284

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Washington University St Louis School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

NCT02529553

Conditions
Advanced Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
  • The START Center for Cancer Care San Antonio, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Vancouver, British Columbia, Canada
View Trial Details
Completed

Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)

NCT03534492

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • ICO Badalona Badalona, Barcelona, Spain
  • Hospital Universitario Central de Asturias Oviedo, Principality of Asturias, Spain
  • Clinica IMQ Zorrotzaurre Bilbao, Spain
  • Hospital San Pedro de Alcántara Cáceres, Spain
View Trial Details

Related conditions